The Nkateko trial

Not Applicable

Completed

• Conditions: Hypertension; Circulatory System; Essential (primary) hypertension

• Registration Number: ISRCTN12128227
• Lead Sponsor: niversity of Warwick

Brief Summary

1. 2014 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/25380994 2. 2018 results in: http://www.ncbi.nlm.nih.gov/pubmed/29527345 3. 2019 health economics results in: https://www.ncbi.nlm.nih.gov/pubmed/30629585 (added 25/09/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-03-05
• Study Completion: 2017-03-21
• Last Update Posted: 29 October 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 8000

Inclusion Criteria

Permanent residents of the Agincourt field site aged over 18 years

Exclusion Criteria

Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome of the trial is a population-level measure of hypertension control and will be derived from cross-sectional surveys carried out before and after the intervention. This primary outcome will be the change between the two surveys in the percentage of people in the population who have elevated blood pressure that is combined with other factors resulting in a risk profile that indicates moderate or greater added risk of cardiovascular disease.